• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CFO, CCO, Secretary, Treasurer Sims David C bought $49,062 worth of shares (5,164 units at $9.50), increasing direct ownership by 3% to 196,837 units (SEC Form 4)

    4/11/25 2:04:26 PM ET
    $GRF
    Finance/Investors Services
    Finance
    Get the next $GRF alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sims David C

    (Last) (First) (Middle)
    225 E. MASON STREET
    SUITE 802

    (Street)
    MILWAUKEE WI 53202

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    EAGLE CAPITAL GROWTH FUND, INC. [ GRF ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    CFO, CCO, Secretary, Treasurer
    3. Date of Earliest Transaction (Month/Day/Year)
    04/09/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/09/2025 P 3,752 A $9.6139 195,425.1 D
    Common Stock 04/10/2025 P 1,412 A $9.2 196,837.1 D
    Common Stock 25,425.733 I By Spouse(1)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or otherwise.
    Carrie Leahy, Attorney-in-Fact by Power of Attorney 04/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GRF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GRF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO, CCO, Secretary, Treasurer Sims David C bought $53,726 worth of shares (5,535 units at $9.71), increasing direct ownership by 2% to 199,897 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      5/2/25 2:29:09 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • CFO, CCO, Secretary, Treasurer Sims David C bought $49,062 worth of shares (5,164 units at $9.50), increasing direct ownership by 3% to 196,837 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      4/11/25 2:04:26 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Amendment: Director Bilkie Robert M disposed of 1,764 shares, acquired 1,764 shares and bought $5,574 worth of shares (600 units at $9.29) (SEC Form 4)

      4/A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      2/14/25 1:29:17 PM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

      The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE:GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024, and the payment date is December 19, 2024. On a preliminary basis, this distribution represents a combination of net investment income of $0.0754 per share, and long-term capital gains of $0.6046 per share. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U. S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund's website after year-end. The Fund is a closed-end investment compan

      11/18/24 4:00:00 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Eagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in Cash

      The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE:GRF) today declared a year-end distribution of $0.35 per share in cash. The record date for this distribution is November 24, 2023, and the payment date is December 15, 2023. On a preliminary basis, this distribution represents a combination of net investment income of $0.07 per share, short-term capital gains of $0.03 per share, and long-term capital gains of $0.25 per share. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U. S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund's website after year-end. T

      10/13/23 5:30:00 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

      BARCELONA, Spain, April 18, 2023 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years, today announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission ("SEC"). Grifols' annual report under Form 20-F is a critical component of the company's commitment to transparency and accountability. The filing of the annual report provides investors with an overview of the company's governance practices, including informa

      4/18/23 10:30:00 AM ET
      $GRF
      $GRFS
      Finance/Investors Services
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Eagle Capital Growth Fund Inc.

      SC 13D - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Subject)

      10/2/23 2:30:30 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form SC 13D/A filed by Eagle Capital Growth Fund Inc. (Amendment)

      SC 13D/A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Subject)

      10/2/23 2:16:33 PM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    SEC Filings

    See more
    • SEC Form DEF 14A filed by Eagle Capital Growth Fund Inc.

      DEF 14A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      3/6/25 12:38:23 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form N-CSR filed by Eagle Capital Growth Fund Inc.

      N-CSR - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      3/6/25 12:30:43 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form N-CEN filed by Eagle Capital Growth Fund Inc.

      N-CEN - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      2/28/25 10:29:16 AM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO, CCO, Secretary, Treasurer Sims David C bought $53,726 worth of shares (5,535 units at $9.71), increasing direct ownership by 2% to 199,897 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      5/2/25 2:29:09 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • CFO, CCO, Secretary, Treasurer Sims David C bought $49,062 worth of shares (5,164 units at $9.50), increasing direct ownership by 3% to 196,837 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      4/11/25 2:04:26 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Allen Jason W. increased direct ownership by 35% to 3,338 units (SEC Form 5)

      5 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      2/14/25 1:48:10 PM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Leadership Updates

    Live Leadership Updates

    See more
    • Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

      BARCELONA, Spain, April 18, 2023 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years, today announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission ("SEC"). Grifols' annual report under Form 20-F is a critical component of the company's commitment to transparency and accountability. The filing of the annual report provides investors with an overview of the company's governance practices, including informa

      4/18/23 10:30:00 AM ET
      $GRF
      $GRFS
      Finance/Investors Services
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care